Figure 1From: Clinical experience with ipilimumab 10 mg/kg in patients with melanoma treated at Italian centres as part of a European expanded access programmeKaplan–Meier analysis of OS among 74 patients receiving ipilimumab 10 mg/kg at Italian centres participating in an EAP. EAP expanded access programme, OS overall survival.Back to article page